Orchestra BioMed Holdings, Inc. (OBIO) NASDAQ

Currency In USD

Orchestra BioMed Holdings, Inc.

Address

150 Union Square Drive

New Hope, PA 18938

United States of America (the)

Phone

215 862 5797

Website

https://orchestrabiomed.com

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

August 04, 2020

Key Executives

Name	Title	Pay	Year Born
David Hochman	Founder, Chairman of the Board of Directors & Chief Executive Officer	1.18M	1975
Andrew Lawrence Taylor	Chief Financial Officer	766,677	1971
Darren R. Sherman	Founder, President, Chief Operating Officer & Director	1.04M	1971
Bob Laughner	Senior Vice President of Regulatory & Quality	0	N/A
Yuval Hay Mika D.Sc	GM & Chief Technology Officer of Bioelectronic Therapies	0	1959
William Reed Little	Executive Vice President of Corporate Development & Strategy	0	1971
Avraham Matityahu Fischer	Senior Vice President of Medical Affairs & Innovation	0	1956
Hans-Peter Stoll	Senior Vice President & Medical Director	0	N/A
Juan Lorenzo	Senior Vice President of Product Development	0	N/A
Lisa Daniels	Vice President of Human Resources	0	N/A

Description

Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo Corporation is dedicated to the development and market introduction of Virtue SAB for artery disease. The company's headquarters are located in New Hope, Pennsylvania.